Enliven Therapeutics
ELVN
#4449
Rank
A$3.52 B
Marketcap
A$57.94
Share price
-1.68%
Change (1 day)
135.59%
Change (1 year)

Annual Reports (10-K)

Latest form 10-K annual reports for Enliven Therapeutics CIK: 0001672619

Thumbnail Enliven Therapeutics 10-K Annual Report

10-K Annual Report 2026-03-03

Language: English

View Annual Report (10-K)
Thumbnail Enliven Therapeutics 10-K Annual Report

10-K Annual Report 2025-03-13

Language: English

View Annual Report (10-K)
Thumbnail Enliven Therapeutics 10-K Annual Report

10-K Annual Report 2024-03-14

Language: English

View Annual Report (10-K)
Thumbnail Enliven Therapeutics 10-K Annual Report

10-K Annual Report 2023-02-10

Language: English

View Annual Report (10-K)
Thumbnail Enliven Therapeutics 10-K Annual Report

10-K Annual Report 2022-03-15

Language: English

View Annual Report (10-K)
Thumbnail Enliven Therapeutics 10-K Annual Report

10-K Annual Report 2021-03-05

Language: English

View Annual Report (10-K)